Bariatric surgery and the gut hormone response

Nutrition in Clinical Practice

Volumn 25, Issue 2, 2010, Pages 175-182

  Thomas, Susan ^a   Schauer, Philip ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Bariatric surgery; Diabetes mellitus; GI hormones; Obesity

Indexed keywords

ADIPONECTIN; ANOREXIGENIC AGENT; CHOLECYSTOKININ; GASTRIC INHIBITORY POLYPEPTIDE; GASTROINTESTINAL HORMONE; GHRELIN; GLUCAGON LIKE PEPTIDE 1; INCRETIN; INTERLEUKIN 6; LEPTIN; PEPTIDE YY; RESISTIN; TUMOR NECROSIS FACTOR ALPHA;

BARIATRIC SURGERY; BODY MASS; COGNITIVE THERAPY; COMORBIDITY; ENDOSCOPIC THERAPY; EPIDEMIC; GLUCOSE METABOLISM; HORMONE RESPONSE; HUMAN; INSULIN RESISTANCE; LONG TERM CARE; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; REMISSION; REVIEW; ROUX Y ANASTOMOSIS; SURGICAL TECHNIQUE; UNITED STATES; WEIGHT REDUCTION;

BARIATRIC SURGERY; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; GLUCAGON-LIKE PEPTIDE 1; GLUCONEOGENESIS; HUMANS; INSULIN; INTESTINE, SMALL; OBESITY, MORBID; WEIGHT LOSS;

EID: 77952577176     PISSN: 08845336     EISSN: None     Source Type: Journal    
DOI: 10.1177/0884533610361739     Document Type: Review

References (54)

1. Centers for Disease Control and Prevention. U.S. obesity trends 1985-2008. Division of Nutrition, Physical Activity and Obesity, National Center for Chronic Disease Prevention and Health Promotion. http://www.cdc.gov/ obesity/data/trends.html. Accessed November 20, 2009.
2. National Institutes of Health, National Heart, Lung, and Blood Institute Obesity Education Initiative. Clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults. http://www.nhlbi.nih.gov/guidelines/obesity/ob-gdlns. pdf. Accessed November 20, 2009.
3. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: General Information National Estimates on Diabetes in the United States, 2007. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2008.
4. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes. Diabetes Care. 2004;27:1047-1053.
5. Puzziferri N, Nakonezny P, Livingston E, Carmody T, Provost D, Rush J. Variations of weight loss following gastric bypass and gastric band. Ann Surg. 2008;248:233-242.
6. Gastrointestinal surgery for severe obesity. NIH Consens Statement. 1991;9:1-20.
7. Cummings D, Overduin J, Foster-Schubert K. Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. J Clin Endocrinol Metab. 2004;89:2608-2615.
8. Maes HH, Neale MC, Eaves LJ. Genetic and environmental factors in relative body weight and human adiposity. Behav Genet. 1997;27:325-351.
9. National Institutes of Health, National Heart, Lung, and Blood Institute. Clinical guidelines on the identification evaluation and treatment of overweight and obesity in adults: the evidence report. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 1998. http://www.nhlbi.nih.gov/guidelines/obesity/ob-home.htm. Accessed November 20, 2009.
10. Bray G, Tartaglia L. Medicinal strategies in the treatment of obesity. Nature. 2000;404:672-677.
11. Schauer P, Chand B, Brethauer S. New applications for endoscopy: the emerging field of endoluminal and transgastric bariatric surgery. Surg Endosc. 2007;21:347-356.
12. Cope MB, Allison DB. Obesity: person and population. Obesity. 2006;14(suppl 4):156S-159.
13. Maggard MA, Shugarman LR, Suttorp M, et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med. 2005;142:547-559.
14. Mun E, Blackburn G, Matthews J. Current status of medical and surgical therapy for obesity. Gastroenterology. 2001;120:669-681.
15. Pories W, Swanson M, MacDonald K, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222:339-352.
16. Craig BM, Tseng DS. Cost-effectiveness of gastric bypass for severe obesity. Am J Med. 2002;113:491-498.
17. Kreen A, Linner J, Nelson C. An experimental evaluation of the nutritional importance of proximal and distal small intestine. Ann Surg. 1954;140:439-448.
18. Griffen W, Bivins B, Bell R. The decline and fall of jejunoileal bypass. Surg Gynecol Obstet. 1983;157:301-308.
19. Scopinaro N, Gianetta E, Adami F, et al. Biliopancreatic diversion for obesity at eighteen years. Surgery. 1996;119:261-268.
20. Hess DS, Hess DW. Biliopancreatic diversion with a duodenal switch. Obes Surg. 1998;8:267-282.
21. Marceau P, Hould F, Simard S, et al. Biliopancreatic diversion with duodenal switch. World J Surg. 1998;22:947-954.
22. Pace W, Martin E, Tetirick T, Fabri P, Carey L. Gastric partitioning for morbid obesity. Ann Surg. 1979;190:392-400.
23. Mason E. Vertical banded gastroplasty for obesity. Arch Surg. 1982;117:701-706.
24. Balsiger B, Poggio J, Mai J, Kelly K, Sarr M. Ten and more years after vertical banded gastroplasty as primary operation for morbid obesity. J Gastrointest Surg. 2004;4:598-605.
25. Belachew M, Belva P, Desaive C. Long-term results of laparoscopic adjustable gastric banding for the treatment of morbid obesity. Obes Surg. 2002;12:564-568.
26. O'Brien P, Dixon J, Brown W, et al. The laparoscopic adjustable gastric band (Lap-Band): a prospective study of medium-term effects on weight, health and quality of life. Obes Surg. 2002;12:652-660.
27. Mason E, Chikashi I. Gastric bypass. Ann Surg. 1968;170:330-339.
28. Wittgrove AC, Clark GW, Tremblay LJ. Laparoscopic gastric bypass, Roux-en-Y: preliminary report of five cases. Obes Surg. 1994;4:353-357.
29. Higa KD, Ho T, Boone KB. Laparoscopic Roux-en-Y gastric bypass: technique and 3-year follow-up. J Laparoendosc Adv Surg Tech A. 2001;11:377-382.
30. Podnos Y, Jimenez J, Wilson S, Stevens M, Nguyen N. Complications after laparoscopic gastric bypass. Arch Surg. 2003;138:957-961.
31. Schauer PR, Ikramuddin S, Gourash W, Ramanathan R, Luketich J. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg. 2000;232:515-529.
32. Baltasar A, Serra C, Perez N, Bou R, Bengochea M, Ferri L. Laparoscopic sleeve gastrectomy: a multi-purpose bariatric operation. Obes Surg. 2005;15:1124-1128.
33. Moon H, Kim W, Oh J. Results of laparoscopic sleeve gastrectomy (LSG) at 1 year in morbidly obese Korean patients. Obes Surg. 2005;15:1469-1475.
34. Sjöströjm L, Lindross AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. New Engl J Med. 2004;351:2683-2693.
35. Pitomob C. Central nervous system regulation and hormonal signaling. In: Pitomobo C, Jones K, Higa K, Pareja C, eds. Obesity Surgery: Principles and Practice. New York, NY: McGraw-Hill; 2008.
36. Cummings D, Weigle D, Frayo R, et al. Plasma ghrelin levels after diet-induces weight loss or gastric bypass surgery. N Engl J Med. 2002;346:1623-1630. (Pubitemid 34755670)
37. Geloneze B, Tambascia MA, Pilla VF, Geloneze SR, Repetto EM, Pareja JC. Ghrelin: a gut-brain hormone: effect of gastric bypass surgery. Obes Surg. 2003;13:17-22.
38. Meier JJ, Goetze O, Anstipp J, et al. Gastric inhibitory polypeptide does not inhibit gastric emptying in humans. Am J Physiol Endocrinol Metab. 2004; 286:E621-E625.
39. Rotter V, Nagaev I, Smith U. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L-1 adipocytes and is like IL-8 and tumor necrosis factor-alpha over expressed in human fat cells from insulin-resistant subjects. J Biol Chem. 2003;278:45777-45784.
40. Vetter ML, Cardillo S, Rickels MR, Iqbal N. Narrative review: effect of bariatric surgery on type 2 diabetes mellitus. Ann Intern Med. 2009;150:94-103.
41. Rubino F, Gagner M, Gentileschi P, et al. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg. 2004;240:236-242.
42. Karamanakos S, Konstantinos V, Kalfarentzos F, Alexandrides T. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy. Ann Surg. 2008;247:401-407.
43. Kashyap SR, Daud S, Kelly KR, et al. Acute effects of gastric bypass versus gastric restrictive surgery on β-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes [published online ahead of print]. Int J Ohes. Published December 22, 2009.
44. Peterli R, Wolnerhanssen B, Peters T, et al. Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy. Ann Surg. 2009;250:234-241.
45. Cummings D, Overduin J, Foster-Schubert K, Carlson M. Role of the bypassed proximal intestine in the anti-diabetic effects of bariatric surgery. Surg Ohes Relat Dis. 2007;3:109-115.
46. Patrita A, Aisa M, Annetti C, et al. How the hindgut can cure type 2 diabetes. Ileal transposition improves glucose metabolism and β-cell function in Goto-kakizaki rats through enhanced proglucagon gene expression and L-cell umber. Surgery. 2007;142:74-85.
47. Rubino F, Forgione A, Cummings D, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg. 2006;244:741-749.
48. Cummings D, Foster-Schubert K, Carlson M, Shannon M, Overduin J. Possible hormonal mechanisms mediating the effects of bariatric surgery. In: Pitomobo C, Jones K, Higa K, Pareja J, eds. Obesity Surgery: Principles and Practice. New York, NY: McGraw-Hill; 2008;137-147.
49. Schauer P, Burguera B, Ikramuddin S, et al. Effect of laparoscopic Roux-en-Y gastric bypass on type 2 diabetes mellitus. Ann Surg. 2003;238:467-485. (Pubitemid 38176385)
50. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;2892: 1724-1737.
51. Moo T, Rubino F. Gastrointestinal surgery as a treatment for type 2 diabetes. Curr Opin Endocrinol Diabetes Ohes. 2008;15: 153-158.
52. Dixon JB, Pories WJ, O'Brien PE, Schauer PR, Zimmet P. Surgery as an effective early intervention for diabesity: why the reluctance? Diahetes Care. 2005; 28:472-474.
53. Frachetti K, Goldfine A. Bariatric surgery for diabetes management. Curr Opin Endocrinol Diahetes Ohes. 2 009;16:119-124.
54. American Diabetes Association. Standards of medical care in diabetes - 2009. Diabetes Care. 2009;32(suppl 1):S13-S61.